[1]Li W,A X M,Li N,et al.Resveratrol inhibits Hexokinases IImediated glycolysis in non-small cell lung cancer via targeting Aktsignaling pathway J ]Experimental Cell Research,2016 (349):320-347.
[2]Sinha D,Sarkar N,Biswas J,et al.Resveratrol for breast cancerprevention and therapy:Preclinical evidence and molecular mecha-nisms [J].Seminars in Cancer Biology,2016:209-232.
[3]Madel Mar Blanquer-Rossell6,Reyniel Hernandez-Lopez,RocaP,et al.Resveratrol induces mitochondrial respiration and apopto-sis in SW620 colon cancer cells [J].Biochimica et Biophysica Ac-ta,2017(1861):431-440.
[4]EC G,Hatziapostolou M,Papadimitriou E.Anticancer activity ofcisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostatecancer cells [J].Eur J Pharm Biopharm,2007,67 (1)1-8.
[5]夏爱晓,宋倩倩,孙渊。固体脂质纳米粒制备及应用研究进展[J].药学实践杂志,2012(05):331-334,368
[6]熊清平,张强华,石莹莹,等.白藜芦醇固体脂质纳米粒体外抗肝癌HepG2细胞的作用研究[J].亚太传统医药,2011,7(09):12-13.
[7]孙聚魁,邓英杰,曹金娜.纳米脂质体研究进展[J].沈阳药科大学学报,2010,27(12):993-997,1002.
[8]陆彬.脂质体、修饰脂质体与改良脂质体给药系统及其进展(上)[J].中国药师,2005,8(05):374-377.
[9]陈琼玲.花生根白藜芦醇提纯、纳米脂质体制备及抗肿瘤活性[D].北京:中国农业科学院,2013.
[10]曾诚,黄伟,何承辉,等.复合磷脂脂质体的研究进展[J]国际药学研究杂志,2015,42(01):91-95.
[11]张秀珍.白藜芦醇复合磷脂脂质体的制备及其体外抗肿瘤作用研究[D].长沙:中南大学,2013.
12]Wang XX,Li Y B,Yao H J,et al.The use of mitochondrialtargeting resveratrol liposomes modified with a dequalinium polyeth-ylene glycol-distearoylphosphatidyl ethanolamine conjugate to in-duce apoptosis in resistant lung cancer cells [J].Biomaterials,2011,32(24):5673-5687.
[13]毛世瑞,田野,王琳琳.药物纳米载体一聚合物胶束的研究进展[J].沈阳药科大学学报,2010,27(12):979-985.
[14]孙奥琪.白藜芦醇聚合物胶束的研制[D].石家庄:河北医科大学,2016.
[15]段兰兰,曾繁明,刘悦,等.纳米微球在药物载体领域的研究进展[J].胶体与聚合物,2015,33(04):175-177.
[16]姜志峰,冯素银,李晓林,等.白藜芦醇载药纳米微球的制备、表征及体外对胶质瘤U251细胞的抑制作用[J].南京医科大学学报(自然科学版),2010,30(09):1240-1244,1310.
[17]李琳.白藜芦醇立方液晶纳米粒的制备及其抗肿瘤作用研究[D].兰州:兰州大学,2015.
[18]吴红兵,翟东风,蒋新国.脂质立方液晶纳米粒作为药物载体的研究进展[J].药学学报,2008(05):450-455. |